"Medtronic is wereldwijd marktleider op het gebied van de medische technologie en helpt miljoenen mensen over de hele wereld hun pijn te verlichten, hun gezondheid te herstellen en hun levensduur te verlengen. Medtronic specialiseert zich in de behandeling van hart- en vaatziekten door middel van pacemakers, defibrillatoren, ballonkatheters en stents. Daarnaast heeft Medtronic nog een breed aanbod van andere producten en therapieën zoals neurostimulatoren, producten voor de behandeling van Parkinson, pijnbestrijding en diabetes. Medtronic zoekt voortdurend naar oplossingen die de kwaliteit van leven van (chronisch) zieke mensen kunnen verbeteren."

During the past decade, Medtronic Bakken Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medtronic Bakken Research Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Medtronic Bakken Research Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Medtronic Bakken Research Center" are "Acute Myocardial Infarction" (2 trials), "Aortic Diseases" (1 trials), "Aortic Valve Stenosis" (1 trials), "Cardiovascular Diseases" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Medtronic Bakken Research Center" in a lesser frequency.

Most popular intervention types in "Medtronic Bakken Research Center" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Engager Transcatheter Aortic Valve Implantation System" (1 trials), "Implantable cardioverter defibrillator" (1 trials), "Managed Ventricular Pacing programmed ON/OFF" (1 trials), "Medtronic Talent Stent-Graft-System" (1 trials) and "Programming (CRT-D, ICD OptiVol® and Cardiac Compass® )" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medtronic Bakken Research Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Medtronic Bakken Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Medtronic Bakken Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medtronic Bakken Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".